Free Trial

Bayesian Capital Management LP Buys New Holdings in Delek US Holdings, Inc. (NYSE:DK)

Delek US logo with Energy background

Bayesian Capital Management LP purchased a new position in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 21,090 shares of the oil and gas company's stock, valued at approximately $390,000.

A number of other hedge funds also recently bought and sold shares of DK. Ameriprise Financial Inc. lifted its stake in Delek US by 14.4% in the fourth quarter. Ameriprise Financial Inc. now owns 792,111 shares of the oil and gas company's stock valued at $14,654,000 after buying an additional 99,521 shares during the last quarter. Mercer Global Advisors Inc. ADV acquired a new position in shares of Delek US in the fourth quarter valued at approximately $532,000. Freestone Grove Partners LP acquired a new position in shares of Delek US in the fourth quarter valued at approximately $209,000. Ion Asset Management Ltd. grew its holdings in Delek US by 16.5% during the fourth quarter. Ion Asset Management Ltd. now owns 3,455,000 shares of the oil and gas company's stock worth $63,918,000 after acquiring an additional 488,509 shares during the period. Finally, Northern Trust Corp boosted its position in Delek US by 8.0% during the fourth quarter. Northern Trust Corp now owns 903,840 shares of the oil and gas company's stock worth $16,721,000 after purchasing an additional 66,815 shares in the last quarter. Institutional investors and hedge funds own 97.01% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on DK shares. Wells Fargo & Company cut their price target on Delek US from $16.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, April 16th. Raymond James dropped their price objective on shares of Delek US from $24.00 to $23.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Mizuho upgraded Delek US from a "neutral" rating to an "outperform" rating and increased their target price for the company from $22.00 to $23.00 in a research note on Tuesday. Morgan Stanley lowered their target price on Delek US from $18.00 to $14.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Finally, UBS Group cut their target price on Delek US from $21.00 to $13.25 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th. Five equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $17.02.

Get Our Latest Report on DK

Delek US Stock Up 4.8%

Shares of DK stock traded up $0.78 on Tuesday, hitting $17.11. 653,308 shares of the stock were exchanged, compared to its average volume of 1,502,417. The business has a 50-day moving average of $14.13 and a 200 day moving average of $16.61. Delek US Holdings, Inc. has a fifty-two week low of $11.02 and a fifty-two week high of $28.91. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 3.18. The firm has a market capitalization of $1.04 billion, a P/E ratio of -3.52 and a beta of 0.74.

Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) EPS for the quarter, missing the consensus estimate of ($2.27) by ($0.05). Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. The company had revenue of $2.64 billion for the quarter, compared to analyst estimates of $2.56 billion. During the same period last year, the company posted ($0.41) earnings per share. The business's revenue for the quarter was down 18.1% on a year-over-year basis. Equities analysts anticipate that Delek US Holdings, Inc. will post -5.5 EPS for the current year.

Delek US Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 19th. Investors of record on Monday, May 12th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Monday, May 12th. This represents a $1.02 annualized dividend and a yield of 5.96%. Delek US's dividend payout ratio (DPR) is presently -9.18%.

Insider Activity at Delek US

In related news, CFO Mark Wayne Hobbs bought 2,800 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were purchased at an average cost of $13.70 per share, with a total value of $38,360.00. Following the acquisition, the chief financial officer now owns 49,138 shares of the company's stock, valued at $673,190.60. This represents a 6.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last ninety days, insiders purchased 5,055 shares of company stock valued at $70,787. Insiders own 1.80% of the company's stock.

Delek US Profile

(Free Report)

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.

Further Reading

Institutional Ownership by Quarter for Delek US (NYSE:DK)

Should You Invest $1,000 in Delek US Right Now?

Before you consider Delek US, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.

While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines